# Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

> **NCT01882816** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 27 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **RADIATION:** IMRT
- **DEVICE:** DWI MRI
- **DRUG:** Doxorubicin
- **OTHER:** Modified Barium Swallow Impairment Profile (MBSImP)

## Key facts

- **NCT ID:** NCT01882816
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-13
- **Primary completion:** 2021-11-04
- **Final completion:** 2021-11-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882816, "Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01882816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*